IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2
Clinical trial NCT03194815 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03194815
- Sponsor
- University of Cambridge
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-01
- Primary completion
- 2027-04-30
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.